The stroke research team has been established since 2006 participating in both commercial and academic stroke trials. The stroke research team was invited to present at The American Heart and Stroke Association annual conference with the findings of our own study.

Contact us: 0151 706 2914.

Current studies:

This study tests whether early treatment with tranexamic acid can safely reduce bleeding and improve outcomes in people with a type of stroke called intracerebral haemorrhage (ICH).It builds on previous research and aims to target patients most likely to benefit, potentially changing stroke care worldwide.

This study is testing whether the antidepressant sertraline can help reduce emotional symptoms like sudden crying or laughing in people after a stroke.It aims to see if taking sertraline daily for six months improves emotional stability and is cost-effective.

This study is testing whether a gentle electrical stimulation to the throat can help stroke patients with swallowing problems recover more quickly.It aims to improve quality of life, reduce hospital stays, and offer a new treatment where none currently exists.

This study is testing whether a new ambulance pathway can speed up access to life-saving stroke surgery by sending patients directly to specialist hospitals.It aims to improve recovery by reducing delays in treatment for people with severe strokes caused by large blood clots.

This study is testing whether a psychological therapy called MIBI can help reduce depression in people shortly after a stroke.It also includes a smaller study to understand what helps people stay involved in clinical trials.

This study is testing whether a simple treatment using a blood pressure cuff on the arm can help protect the brain and reduce disability after a stroke. The treatment, remote ischaemic conditioning, may trigger the body to release protective chemicals and will be tested in stroke patients over 90 days.

This study is testing whether a drug, metoclopramide, can help prevent pneumonia and improve survival in people after a stroke. It aims to reduce complications by stopping vomiting and regurgitation, which are major causes of pneumonia in stroke patients.

This study will test how easy and effective the Cognishine platform is for NHS staff to use when delivering rehabilitation therapy to patients. The results will help design a larger study to see if using the platform improves patient recovery by boosting therapy participation.

This study is testing whether gentle nerve stimulation through the ear, combined with home-based arm exercises, can improve arm movement in people recovering from stroke. It aims to offer a non-invasive, at-home therapy that could boost recovery even years after a stroke.